BioSpace News Archive

Millar, Inc., medical device manufacturer and OEM pressure sensor integration partner, today announced the appointment of Dr. Alfred Coats as Chairman of the Board for Millar, Inc.

New and improved mobile app and upcoming NCCN Global Academy event reflect the organization’s efforts to increase worldwide access to NCCN resources. #NCCNGlobal

Centene Corporation (NYSE: CNC) announced today it will present at the Wells Fargo Securities 2019 Healthcare Conference, to be held September 4-5, at the Westin Copley Plaza in Boston.

Two experienced healthtech industry leaders today announced the launch of MDisrupt, the first medical diligence company for the healthtech industry.

Medical device company Q-Sera Pty Ltd today announces that it has received a Notice of Allowance from the United States Patent & Trademark Office for the foundation patent of its innovative blood clotting technology for use in blood collection tubes.

Vyntus™ ONE, Vyntus™ BODY and SentrySuite™ Software Available to U.S. Healthcare Market Immediately

Oragenics, Inc. (NYSE American: OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), today announces it will be presenting a talk titled “Lantibiotics, a Novel Class of Antibiotics in the Pharmacopeia”, which will be part of a session dedicated to novel antimicrobial developments to counter multidrug-resistant bacterial infections in military personnel.

In the second quarter, order intake rose 80 percent and net sales grew 34 percent.

Orexo AB announces it has entered into an exclusive agreement with GAIA AG, a global leader in digital therapeutics that successfully launched its first digital health product in 2001, for a new digital therapy for the treatment of Opioid Use Disorder.

AKL Research and Development, a company developing an investigational osteoarthritis medicine, announces the appointment of Michael Martin as its Chief Financial Officer.